Prostate Brachytherapy: No Increased Risk of Bladder or Rectal Cancer

Clinical trials and systematic reviews consistently show that prostate brachytherapy (low-dose-rate or high-dose-rate radioactive seed implantation) does not increase the incidence of secondary bladder or rectal cancers. The precise, localized radiation delivery spares surrounding tissues, minimizing the risk of radiation-induced malignancies.